HSBC analyst Morten Herholdt downgraded Amgen (NASDAQ: AMGN) from Buy to Hold with a price target of $425.00 (from $445.00).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades